Cannabis and HRV: What Your Wearable Data Reveals

Your Wristwatch Knows You’re High

Here’s something wild: that little sensor on the back of your Apple Watch, Oura Ring, or WHOOP strap is quietly collecting one of the most telling biomarkers in modern health science — heart rate variability, or HRV. And if you’ve ever glanced at your morning readiness score after a cannabis session the night before, you’ve probably noticed something… off.

Maybe your HRV dipped. Maybe your resting heart rate climbed a few beats. Maybe your “recovery score” tanked even though you slept like a rock. What’s going on?

HRV has become the wellness world’s favorite metric for measuring stress, recovery, and overall nervous system balance. WHOOP, Oura Ring, and Apple Watch have each made it a centerpiece of their recovery tracking — and tens of millions of people now wake up to a number that tells them how “recovered” their body is. But when cannabis enters the picture, that number gets complicated fast.

Real-world wearable data from WHOOP members confirms what researchers have observed in the lab: cannabis use correlates with an average resting heart rate increase of 1 bpm and an HRV dip of approximately 2.8 milliseconds the following morning (WHOOP, 2022). Those numbers sound small — but for someone whose baseline HRV is 35 ms, a 2.8 ms drop is actually meaningful.

Today, we’re going to decode what your wearable is telling you. We’ll look at the science of HRV, how cannabinoids interact with your heart and autonomic nervous system, and — most importantly — what you can actually do with this information to optimize your wellness routine.

No panic required. A single night of lower HRV doesn’t mean cannabis is harming you. Context matters enormously, and by the end of this article, you’ll know how to read yours.

The Science Explained

How Heart Rate Variability Works

First, let’s demystify HRV. Despite the name, it’s not about how fast your heart beats — it’s about the variation in time between each heartbeat.

Think of it like this: imagine a drummer keeping a steady beat at 60 beats per minute. You’d expect one beat every second, right? But a healthy heart doesn’t work like a metronome. The gaps between beats constantly fluctuate — maybe 0.95 seconds, then 1.07 seconds, then 0.98 seconds. That variability is a good thing.

Higher HRV generally signals a flexible, resilient nervous system — your body can smoothly shift between “go mode” (the sympathetic nervous system) and “rest mode” (the parasympathetic nervous system). Lower HRV often indicates stress, fatigue, illness, or that your body is working harder to maintain balance.

Your autonomic nervous system (ANS) — the autopilot that controls heart rate, digestion, and breathing — is the conductor here. And this is exactly where cannabis enters the picture, because the endocannabinoid system (ECS) is deeply woven into autonomic regulation.

Wearables measure HRV using slightly different methods. Oura Ring and WHOOP both use RMSSD (root mean square of successive differences) — a measure of beat-to-beat variation especially sensitive to parasympathetic tone. Apple Watch uses SDNN (standard deviation of all R-R intervals), which captures a broader mix of sympathetic and parasympathetic activity. These are not directly comparable numbers, which matters when cross-referencing research studies (most use RMSSD) with your Apple Watch readings.

What the Research Shows: A Nuanced Picture

The relationship between cannabis and cardiovascular function is complex, and the research reflects that complexity. Here’s the key finding that trips most people up: acute effects and chronic effects run in opposite directions.

Acute THC Use: Sympathetic Surge

The short-term effects are well-documented. Cannabis consumption — particularly THC-dominant products — typically produces a temporary increase in heart rate (tachycardia) of 20–50% above baseline within minutes of inhalation [Jouanjus et al., 2014]. A 2024 study published in the Journal of the American Heart Association confirmed that THC-predominant cannabis (both smoked and vaped) increased heart rate by ~17 bpm and mean arterial pressure by ~7 mmHg, effects that were not seen with CBD-predominant cannabis [Burr et al., 2024].

This is a sympathetic nervous system response. THC binds to CB1 receptors in the cardiovascular system, reduces vagal tone, and promotes vasodilation — all of which trigger a reflex heart rate increase. The downstream effect on HRV: a meaningful suppression of the high-frequency (HF) component, which reflects parasympathetic activity. In plain terms, your nervous system temporarily loses some of its flexibility.

CBD: A Different Cardiovascular Profile

CBD appears to work quite differently. Research suggests CBD may actually support parasympathetic tone (your “rest and digest” system) rather than suppress it. The same 2024 JAHA study found that CBD-predominant cannabis did not significantly alter heart rate or blood pressure — a striking contrast to THC. A separate FASEB study found that increasing doses of CBD (25 mg, 50 mg, 200 mg) appeared to increase RMSSD and SDNN in young adults, suggesting enhanced parasympathetic activity [Razanouski et al., 2022].

One 2024 clinical trial adds further nuance: in chronic pain patients, oral THC actually shifted autonomic balance toward increased parasympathetic tone and reduced the LF/HF ratio — the opposite of what acute inhalation studies show [Jacob et al., 2024]. This suggests that route of administration, dose, and the patient’s baseline ANS state all modulate the outcome significantly.

Chronic Use: The Surprising Finding

Here’s where things get counterintuitive. A study by Schmid et al. (2010) found that chronic cannabis users actually had significantly higher RMSSD at rest (56.2 ms vs. 48.6 ms in controls, p<0.05), and a lower LF/HF ratio — indicating greater parasympathetic dominance compared to non-users. A 2025 cross-sectional study of young adults found that chronic combusted cannabis use alone (without co-use of nicotine e-cigarettes) was not associated with reduced HRV [Hampilos et al., 2025].

This doesn’t mean chronic use is without risk — but it does mean that what your wearable shows the morning after a session (acute suppression) is physiologically distinct from what long-term trends might look like.

The duration of acute effects also matters. Most cardiovascular changes from inhalation resolve within 2–3 hours. But wearables capture overnight HRV, meaning your morning score may reflect the residual recovery process — and, critically, how cannabis disrupted your sleep architecture — rather than active THC impairment itself.

Important caveat: Most existing research involves isolated THC or CBD, not the full-spectrum products most people actually use. The entourage effect — where multiple cannabinoids and terpenes interact — likely modulates cardiovascular responses in ways not yet fully studied [Russo, 2011].

Reading Your Wearable Data Intelligently

The Sleep Architecture Connection

Before jumping to “cannabis wrecked my HRV,” consider what’s actually happening overnight. Cannabis — specifically THC — suppresses REM sleep, the stage most closely tied to next-day HRV. Less REM sleep means less parasympathetic restoration, which shows up as lower RMSSD in the morning. Oura’s own sleep scientist Matthew Walker, PhD, has noted that cannabis can lead to greater long-term sleep disruption even as it helps people fall asleep faster. (For a deep dive on the sleep side of this equation, see our cannabis and sleep science guide.)

So when WHOOP members who log marijuana use show a 1% drop in restorative sleep (a shift from 46% to 45% of time in REM and slow-wave combined), that’s a meaningful signal. The HRV dip you’re seeing may be downstream of sleep quality degradation as much as any direct cardiovascular effect.

How to Use Your Wearable Data for Optimization

So your Oura Ring says your HRV dropped after a session. Here’s how to think about it — and what to actually do.

1. Track patterns, not single nights. One low HRV reading means very little. Bodies fluctuate. Look at your data over weeks and months. Does HRV consistently dip on consumption nights? By how much? Does it recover by the next day? Trends tell the story; individual data points are just noise. Both Oura and WHOOP let you add custom tags — use them. Tag your sessions with product type, dose, and timing, then compare trends after 4 weeks.

2. Consider your product’s cannabinoid profile. THC-dominant products are more likely to produce acute cardiovascular effects. If you’re noticing consistent HRV dips, you might experiment with products that include higher CBD ratios or strains from the Relaxing High family, which tend to feature myrcene and meaningful CBD content. The Balancing High family — known for gentler, more beginner-friendly effects — may also produce less cardiovascular disruption.

3. Timing matters more than most people realize. Consuming earlier in the evening gives your body more time to return to baseline before your wearable captures its overnight readings. A session at 6 PM will look very different in your data than one at 11 PM. Research suggests most acute cardiovascular effects from inhalation resolve within 2–3 hours — so a 3-hour buffer before sleep is a reasonable baseline target.

4. Physical fitness is a buffer. A 2026 study found that highly active individuals experienced no significant heart rate changes after THC edible use, while low and moderately active participants showed dose-dependent increases [Sundali et al., 2026]. If you train consistently, your cardiovascular system is more resilient to THC’s acute effects.

5. Pair with parasympathetic support. Breathwork, meditation, and gentle stretching after a session may help your nervous system shift back toward “rest mode” more efficiently. Some users report that combining cannabis with a 10-minute box breathing or 4-7-8 breathing practice noticeably improves their next-day HRV scores.

6. Dose low, go slow. THC’s cardiovascular effects are dose-dependent — this is one of the most consistent findings in the literature. Lower doses of THC produce smaller, shorter-lived heart rate increases [Jouanjus et al., 2014]. If HRV optimization is a priority, microdosing or low-dose edibles may be worth exploring over high-THC flower.

Strain-Specific HRV Patterns: What We Know (and Don’t)

Direct strain-level HRV research doesn’t yet exist — we simply don’t have clinical trials comparing OG Kush to Blue Dream on an Oura Ring. But we can reason from what we know about cannabinoid and terpene profiles:

Higher-CBD, lower-THC strains are the most logical candidates for HRV-friendly use, given CBD’s neutral-to-positive cardiovascular profile in multiple studies. Balanced 1:1 THC:CBD products may produce less acute HRV suppression than high-THC isolate products.

Myrcene-dominant strains (common in relaxation-oriented varieties) are associated with sedative effects, which may support parasympathetic tone indirectly through improved sleep depth.

Linalool-containing strains (the lavender terpene) have shown anxiolytic properties in some research, which could support HRV by reducing the stress-response component of cannabis’s cardiovascular effects [Guzmán-Gutiérrez et al., 2015].

High-THC concentrates (wax, shatter, live rosin) carry the most cardiovascular load — the same 2024 JAHA study that found ~17 bpm heart rate increases used inhalation methods comparable to flower. Concentrates deliver significantly more THC per puff and would be expected to produce larger, longer-lasting HRV suppression.

The bottom line on strain selection: until personalized HRV + cannabinoid research matures, your own wearable data is currently the best tool you have for understanding which products work with your nervous system.

Key Takeaways

• HRV measures your nervous system’s flexibility, and cannabis — especially THC — temporarily shifts it toward sympathetic (“go mode”) dominance, which may lower your overnight HRV readings.
• CBD appears to have a different cardiovascular profile than THC, with early research suggesting it may support parasympathetic tone rather than suppress it.
• Single-night HRV dips are normal and not cause for alarm. Track trends over weeks to get meaningful insights about how cannabis affects your body.
• Timing, dose, and cannabinoid ratios all influence the magnitude of HRV changes. Earlier sessions, lower doses, and balanced CBD:THC products may minimize impact.
• Your wearable data is a tool, not a verdict. Use it to experiment mindfully and find the consumption patterns that align with your wellness goals.
• Cannabis affects more than just HRV. If you’re tracking performance and recovery, read our companion piece on cannabis and athletic recovery for the full picture.

FAQs

Does cannabis permanently lower HRV?

Current research does not suggest that moderate cannabis use causes lasting changes to HRV. Acute effects typically resolve within hours [Pacher et al., 2018]. However, long-term, heavy daily use has not been studied extensively in the context of HRV, so more research is needed.

Should I stop using cannabis if my HRV drops?

Not necessarily. A temporary HRV dip is a normal physiological response to many things — alcohol, intense exercise, poor sleep, and stress all do it too. If you notice a consistent, significant pattern that concerns you, consider adjusting your dose, timing, or product type, and consult a healthcare provider if you have cardiovascular concerns.

Do edibles affect HRV differently than smoking?

Likely yes, though direct comparative HRV studies are limited. Edibles produce a slower onset and longer duration of effects, which may mean a more gradual but prolonged cardiovascular response. Inhalation produces a sharper, shorter spike in heart rate [Jouanjus et al., 2014].

Which terpenes might support better HRV outcomes?

This is an emerging area, but linalool (associated with calming effects) and myrcene (associated with relaxation) are found in strains from the Relaxing High and Uplifting High families. Some early research suggests linalool may have anxiolytic properties that could support parasympathetic function [Guzmán-Gutiérrez et al., 2015], but direct HRV studies on individual terpenes are still lacking.

Sources

• Burr, J.F., et al. (2024). “Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function.” Journal of the American Heart Association, e037731. doi:10.1161/JAHA.124.037731
• Glodosky, N.C., et al. (2024). “Multimodal examination of daily stress rhythms in chronic cannabis users.” Psychopharmacology, 243, 251–274. doi:10.1007/s00213-024-06709-3
• Hampilos, K., et al. (2025). “Ventricular Repolarization in Healthy Young Adults Who Use Combusted Cannabis.” Journal of the American Heart Association, e041460. PMC12449963
• Jacob, G., et al. (2024). “Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain.” CNS Drugs, 38(5), 375–385. PMC11026292
• Jouanjus, E., Lapeyre-Mestre, M., & Micallef, J. (2014). “Cannabis use: signal of increasing risk of serious cardiovascular disorders.” Journal of the American Heart Association, 3(2), e000638. PMID: 24760961
• Pacher, P., Steffens, S., Haskó, G., Schindler, T.H., & Kunos, G. (2018). “Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.” Nature Reviews Cardiology, 15(3), 151–166. PMID: 28983062
• Razanouski, Z., & Corcoran, A. (2022). “The Effects of Acute Cannabidiol on Autonomic Balance.” The FASEB Journal, 36(S1). doi:10.1096/fasebj.2022.36.S1.R4524
• Russo, E.B. (2011). “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.” British Journal of Pharmacology, 163(7), 1344–1364. PMID: 21749363
• Schmid, K., Schönlebe, J., Drexler, H., & Mueck-Weymann, M. (2010). “The effects of cannabis on heart rate variability and well-being in young men.” Pharmacopsychiatry, 43(4), 147–152. PMID: 20178093
• Sundali, E., Lisano, J.K., Bryan, A.D., & Skrzynski, C.J. (2026). “Heart rate response to cannabis in active older adults.” European Journal of Applied Physiology. doi:10.1007/s00421-026-06152-6
• WHOOP. (2022). “Impact of Marijuana (THC) on Sleep, Heart Rate & HRV.” whoop.com/thelocker
• Guzmán-Gutiérrez, S.L., et al. (2015). “Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway.” Life Sciences, 128, 24–29. PMID: 25771248